Adverse Effects of GLP-1 Receptor Agonists.

Filippatos, Theodosios D et al.·The review of diabetic studies : RDS·2014·

Quick Facts

Study Type

Not classified

Evidence

Not graded

Sample

Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:: Adverse Effects of GLP-1 Receptor Agonists.
Published In:: The review of diabetic studies : RDS, 11(3-4), 202-30 (2014)
Authors:: Filippatos, Theodosios D, Panagiotopoulou, Thalia V, Elisaf, Moses S
Database ID:: RPEP-02384

Evidence Hierarchy

Meta-Analysis / Systematic Review

Randomized Controlled Trial

Cohort / Case-Control

Cross-Sectional / ObservationalSnapshot without intervening

This study

Case Report / Animal Study

What do these levels mean? →

Cite This Study

RPEP-02384·https://rethinkpeptides.com/research/RPEP-02384

APA

Filippatos, Theodosios D; Panagiotopoulou, Thalia V; Elisaf, Moses S. (2014). Adverse Effects of GLP-1 Receptor Agonists.. The review of diabetic studies : RDS, 11(3-4), 202-30. https://doi.org/10.1900/RDS.2014.11.202

MLA

Filippatos, Theodosios D, et al. "Adverse Effects of GLP-1 Receptor Agonists.." The review of diabetic studies : RDS, 2014. https://doi.org/10.1900/RDS.2014.11.202

RethinkPeptides

RethinkPeptides Research Database. "Adverse Effects of GLP-1 Receptor Agonists." RPEP-02384. Retrieved from https://rethinkpeptides.com/research/filippatos-2014-adverse-effects-of-glp1

Access the Original Study

View on PubMed View via DOI

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.

← Back to Research Database